MARIA E RAMOS CORTES
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SAN JUAN, PR NPI 1104882224
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease PR Janssen Pharmaceuticals, Inc All categories
General Payments — all program years on this page
$9,377.13
- Category: General Payments
- Program years: PY2018–2024
- Record count: 125
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $514.90 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $514.90 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $203.31 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $120.27 | 2 |
| Amgen Inc. | $118.71 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $52.72 | 1 |
| Acerta Pharma LLC | $19.89 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078171477 | Janssen Pharmaceuticals, Inc | $24.98 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078171951 | Janssen Pharmaceuticals, Inc | $78.33 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078172175 | Janssen Pharmaceuticals, Inc | $100.00 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092236172 | Boston Scientific Corporation | $52.72 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104288184 | AstraZeneca Pharmaceuticals LP | $19.89 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111683873 | Amgen Inc. | $118.71 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117875323 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20.00 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117875325 | Boehringer Ingelheim Pharmaceuticals, Inc. | $100.27 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.